Neurological & CognitiveLimited ResearchResearch Only

DSIP

Delta Sleep-Inducing Peptide ยท Proposed modulation of delta-wave sleep via thalamic and hypothalamic mechanisms; interaction with sigma receptors and opioid pathways; reduction of ACTH and LH secretion; antioxidant properties via lipid peroxidation inhibition

Not medical advice. For educational and research reference only.

Typical Dose

25โ€“100 mcg (research; no established human dose)

Route

Injectable

Cycle

Protocol-dependent

Storage

2โ€“8ยฐC Refrigerated

What is DSIP?

Delta sleep-inducing peptide (DSIP) is a nonapeptide first isolated in 1977 from thalamic perfusate of sleeping rabbits by Monnier et al. that induced slow-wave (delta) sleep when infused. Subsequent research has explored roles in pain modulation, stress response, temperature regulation, and antioxidant effects. Clinical evidence is limited and inconsistent; mechanism remains poorly characterized. Research only.

Mechanism of Action

Proposed modulation of delta-wave sleep via thalamic and hypothalamic mechanisms; interaction with sigma receptors and opioid pathways; reduction of ACTH and LH secretion; antioxidant properties via lipid peroxidation inhibition

Target: Sigma receptors, hypothalamic-pituitary axis, thalamic sleep centers

Research Indications

Cognitive FunctionEffective

Research suggests improvements in memory, focus, and cognitive processing

NeuroprotectionModerate

May protect neurons from oxidative stress and inflammatory damage

Mood & AnxietyModerate

Some studies report anxiolytic and mood-stabilizing effects

Research Protocols

These are commonly discussed research protocols โ€” not medical advice. Consult a healthcare provider before use.

GoalDoseFrequencyRoute
Starting DoseLow doseOnce dailyIntranasal or Injectable
Standard DoseStandardOnce dailyIntranasal or Injectable

Peptide & Drug Interactions

Always consult your healthcare provider before combining with other compounds. Use our Interaction Checker for reference.

Stimulants (Modafinil, Adderall)Caution
MAOIs / SSRIsMonitor
RacetamsCaution
NAD+Compatible
BPC-157Compatible

How to Reconstitute & Inject

Use bacteriostatic (BAC) water only. Avoid saline โ€” may cause precipitation. Refrigerate and use within 28 days.

  1. 1

    Remove DSIP vial from refrigeration and allow to reach room temperature (15โ€“20 minutes)

  2. 2

    Clean vial top with alcohol swab and allow to air dry completely

  3. 3

    Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water)

  4. 4

    Inject BAC water slowly down the side of the vial โ€” do not aim directly at the powder

  5. 5

    Gently swirl in circular motions โ€” DO NOT shake vigorously as this degrades the peptide

  6. 6

    Allow 2โ€“3 minutes for full dissolution โ€” solution should be clear and colorless

  7. 7

    Draw calculated dose into an insulin syringe for subcutaneous injection

  8. 8

    Inject into abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy

  9. 9

    Store reconstituted solution refrigerated (2โ€“8ยฐC) and use within 28 days

What to Expect

Week 1โ€“2

Subtle mood and focus improvements may begin. Sleep quality often improves early.

Week 2โ€“4

Increased mental clarity, word recall, and reduced brain fog reported by many.

Week 4โ€“8

Consistent cognitive improvements. Better stress response and working memory.

Week 8+

Sustained cognitive and neurological benefits. Effects may persist post-cycle.

Side Effects & Safety

  • Headache, particularly at initiation
  • Mild anxiety or restlessness with some compounds
  • Nasal irritation (intranasal administration)
  • Sleep disturbance if dosed too close to bedtime
  • Rare: Mood changes or emotional lability

FDA Status & Regulatory Info

Research Only

Delta sleep-inducing peptide (DSIP) is a nonapeptide first isolated in 1977 from thalamic perfusate of sleeping rabbits by Monnier et al. that induced slow-wave (delta) sleep when infused. Subsequent research has explored roles in pain modulation, stress response, temperature regulation, and antioxidant effects. Clinical evidence is limited and inconsistent; mechanism remains poorly characterized. Research only.

Rx Required: No
503A Ban: No
Telehealth: N/A
Full FDA Status Tracker

Frequently Asked Questions

Research References

External links for education only. We do not control third-party content.

Community-reported data

The information below reflects self-reported experiences from PeptIQ app users. It is not clinical evidence and should not replace professional medical advice.

Community Intelligence

What 49 users report

49 community reports

Positive 3% ยท Neutral 97% ยท Negative 0%

Most reported benefits

Sleep
182
Mood
182

Most reported side effects

Headache
177

Dose distribution

Median: 200โ€“400 mcg ยท Most common: 200โ€“400 mcg

0โ€“25
0
25โ€“50
5
50โ€“100
2
100โ€“200
38
200โ€“400
131
400โ€“600
6
600โ€“1000
0
1000โ€“2000
0
2000+
0

How repeat users are trending

Among repeat reporters, 85% said they felt similar to their last entry, 15% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 62 days ยท Based on 33 repeat reporters

Share Your Experience

Rate DSIP in the PeptIQ app and help the community make informed decisions.

Research purposes only

This page is for educational reference. It is not medical or legal advice. Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.